{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:18:23Z","timestamp":1794867503866,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Clinical Projects of Peking University Third Hospital","award":["BYSYFY2021046"],"award-info":[{"award-number":["BYSYFY2021046"]}],"id":[{"id":"https:\/\/ror.org\/04wwqze12","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CSCO Clinical Oncology Research Foundation of Beijing","award":["Y-tongshu2021\/ms-0072"],"award-info":[{"award-number":["Y-tongshu2021\/ms-0072"]}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["Z230014"],"award-info":[{"award-number":["Z230014"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1245\/s10434-026-20061-0","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:24:18Z","timestamp":1790180658000},"page":"11644-11653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preoperative Renal Impairment as an Independent Determinant of Poor Survival After Concomitant Laparoscopic Radical Cystectomy and Nephroureterectomy"],"prefix":"10.1245","volume":"33","author":[{"given":"Dandan","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenmo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganglian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Jianfei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"20061_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin."},{"key":"20061_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2022.08.064","author":"JD Subiela","year":"2023","unstructured":"Subiela JD, Gonz\u00e1lez-Padilla DA, Huguet J, et al. Oncological and renal function outcomes in patients who underwent simultaneous radical cystectomy and nephroureterectomy for synchronous or metachronous panurothelial carcinoma. Urology. 2023. https:\/\/doi.org\/10.1016\/j.urology.2022.08.064.","journal-title":"Urology."},{"issue":"2","key":"20061_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0022-5347(01)65180-2","volume":"157","author":"C Goessl","year":"1997","unstructured":"Goessl C, Knispel HH, Miller K, Kl\u00e4n R. Is routine excretory urography necessary at first diagnosis of bladder cancer? J Urol. 1997;157(2):480\u2013541.","journal-title":"J Urol."},{"key":"20061_CR4","doi-asserted-by":"publisher","DOI":"10.1159\/000068001","author":"F Herranz-Amo","year":"1999","unstructured":"Herranz-Amo F, Diez-Cordero JM, Verd\u00fa-Tartajo F, Bueno-Chom\u00f3n G, Leal-Hern\u00e1ndez F, Bielsa-Carrillo A. Need for intravenous urography in patients with primary transitional carcinoma of the bladder? Eur Urol. 1999. https:\/\/doi.org\/10.1159\/000068001.","journal-title":"Eur Urol."},{"key":"20061_CR5","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.167.3.3363119","author":"DM Yousem","year":"1988","unstructured":"Yousem DM, Gatewood OM, Goldman SM, Marshall FF. Synchronous and metachronous transitional cell carcinoma of the urinar y tract: prevalence, incidence, and radiographic detection. Radiology. 1988. https:\/\/doi.org\/10.1148\/radiology.167.3.3363119.","journal-title":"Radiology."},{"key":"20061_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1233125","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang H, Wen Z, et al. Simultaneous radical cystectomy and nephroureterectomy in the treatment of panurothelial carcinoma: a systematic review and single-arm meta-analysis. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1233125.","journal-title":"Front Oncol."},{"key":"20061_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep18014","author":"D Fang","year":"2015","unstructured":"Fang D, Liu P, Li X, et al. Characteristics and treatment outcomes of pan-urothelial cell carcinom a: a descriptive analysis of 45 patients. Sci Rep. 2015. https:\/\/doi.org\/10.1038\/srep18014.","journal-title":"Sci Rep."},{"key":"20061_CR8","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2017.0283","author":"Y Osman","year":"2018","unstructured":"Osman Y, Harraz AM, El-Halwagy S, et al. Acute kidney injury following radical cystectomy and urinary diversion: predictors and associated morbidity. Int Braz J Urol. 2018. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2017.0283.","journal-title":"Int Braz J Urol."},{"key":"20061_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.023","author":"A Masson-Lecomte","year":"2025","unstructured":"Masson-Lecomte A, Birtle A, Pradere B, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update. Eur Urol. 2025. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.023.","journal-title":"Eur Urol"},{"key":"20061_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.05.003","author":"KS Faraj","year":"2020","unstructured":"Faraj KS, Mi L, Eversman S, et al. The effect of urinary diversion on long-term kidney function after cystectomy. Urol Oncol. 2020. https:\/\/doi.org\/10.1016\/j.urolonc.2020.05.003.","journal-title":"Urol Oncol."},{"key":"20061_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.09.004","author":"XD Jin","year":"2012","unstructured":"Jin XD, Roethlisberger S, Burkhard FC, Birkhaeuser F, Thoeny HC, Studer UE. Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol. 2012. https:\/\/doi.org\/10.1016\/j.eururo.2011.09.004.","journal-title":"Eur Urol."},{"key":"20061_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2022.12.010","author":"Z Wu","year":"2022","unstructured":"Wu Z, Chen Q, Djaladat H, et al. A preoperative nomogram to predict renal function insufficiency for cisplatin-based adjuvant chemotherapy following minimally invasive radical nephroureterectomy (ROBUUST Collaborative Group). Eur Urol Focus. 2022. https:\/\/doi.org\/10.1016\/j.euf.2022.12.010.","journal-title":"Eur Urol Focus."},{"key":"20061_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.04.001","author":"G Xiong","year":"2014","unstructured":"Xiong G, Chen X, Li X, et al. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients. J Formos Med Assoc. 2014. https:\/\/doi.org\/10.1016\/j.jfma.2013.04.001.","journal-title":"J Formos Med Assoc."},{"key":"20061_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.03.120","author":"Q Li","year":"2017","unstructured":"Li Q, Assel M, Benfante N, et al. Clinical outcomes in patients with panurothelial carcinoma treated with radical nephroureterectomy following cystectomy for metachronous recurrence. J Urol. 2017. https:\/\/doi.org\/10.1016\/j.juro.2017.03.120.","journal-title":"J Urol."},{"key":"20061_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.04.001","author":"K Muramoto","year":"2024","unstructured":"Muramoto K, Urabe F, Koike Y, et al. Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: a multicenter retrospective study. Urol Oncol. 2024. https:\/\/doi.org\/10.1016\/j.urolonc.2024.04.001.","journal-title":"Urol Oncol."},{"key":"20061_CR16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8433","author":"MD Galsky","year":"2011","unstructured":"Galsky MD, Hahn NM, Rosenberg J, et al. Treatment of patients with metastatic urothelial cancer \u201cunfit\u201d for cisplatin-based chemotherapy. J Clin Oncol. 2011. https:\/\/doi.org\/10.1200\/JCO.2011.34.8433.","journal-title":"J Clin Oncol."},{"key":"20061_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-023-04590-x","author":"PE Gabriel","year":"2023","unstructured":"Gabriel PE, Pinar U, Lenfant L, et al. Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma. World J Urol. 2023. https:\/\/doi.org\/10.1007\/s00345-023-04590-x.","journal-title":"World J Urol."},{"key":"20061_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.01.005","author":"PJ Hensley","year":"2024","unstructured":"Hensley PJ, Labbate C, Zganjar A, et al. Development and validation of a multivariable nomogram predictive of post-nephroureterectomy renal function. Eur Urol Oncol. 2024. https:\/\/doi.org\/10.1016\/j.euo.2024.01.005.","journal-title":"Eur Urol Oncol."},{"issue":"6","key":"20061_CR19","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.euo.2024.04.012","volume":"7","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xu C, Mou Z, et al. Endoscopic cryoablation versus radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol Oncol. 2024;7(6):1453\u201361.","journal-title":"Eur Urol Oncol."},{"key":"20061_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87573-5","author":"TH Kim","year":"2021","unstructured":"Kim TH, Lee CU, Kang M, et al. Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-87573-5.","journal-title":"Sci Rep."},{"key":"20061_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14719","author":"A Martini","year":"2019","unstructured":"Martini A, Daza J, Poltiyelova E, et al. Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upper tract urothelial carcinoma. BJU Int. 2019. https:\/\/doi.org\/10.1111\/bju.14719.","journal-title":"BJU Int."},{"key":"20061_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.01.058","author":"X Meng","year":"2019","unstructured":"Meng X, Chao B, Vijay V, et al. High response rates to neoadjuvant chemotherapy in high-grade upper tract urothelial carcinoma. Urology. 2019. https:\/\/doi.org\/10.1016\/j.urology.2019.01.058.","journal-title":"Urology."},{"key":"20061_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.09.047","author":"JE Gschwend","year":"2019","unstructured":"Gschwend JE, Heck MM, Lehmann J, et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. Eur Urol. 2019. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.047.","journal-title":"Eur Urol."},{"key":"20061_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2022.01.007","author":"A Abrate","year":"2022","unstructured":"Abrate A, Sessa F, Sessa M, et al. Segmental ureterectomy versus radical nephroureterectomy in older patients treated for upper tract urothelial carcinoma. Clin Genitourin Cancer. 2022. https:\/\/doi.org\/10.1016\/j.clgc.2022.01.007.","journal-title":"Clin Genitourin Cancer."},{"key":"20061_CR25","doi-asserted-by":"publisher","DOI":"10.7150\/jca.76977","author":"HS Kim","year":"2023","unstructured":"Kim HS, Lee HS, Ku JH. Prognostic impact of postoperative neutrophil-to-lymphocyte ratio on survival outcomes of patients treated with radical nephroureterectomy for upper urinary tract urothelial carcinoma: a single institution retrospective analysis using propensity score matching. J Cancer. 2023. https:\/\/doi.org\/10.7150\/jca.76977.","journal-title":"J Cancer."},{"key":"20061_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.12.027","author":"M Marchioni","year":"2017","unstructured":"Marchioni M, Cindolo L, Autorino R, et al. High neutrophil-to-lymphocyte ratio as prognostic factor in patients affected by upper tract urothelial cancer: a systematic review and meta-analysis. Clin Genitourin Cancer. 2017. https:\/\/doi.org\/10.1016\/j.clgc.2016.12.027.","journal-title":"Clin Genitourin Cancer."},{"key":"20061_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16025","author":"D Tamura","year":"2024","unstructured":"Tamura D, Abe M, Hiraki H, et al. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Sci. 2024. https:\/\/doi.org\/10.1111\/cas.16025.","journal-title":"Cancer Sci."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20061-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:35:19Z","timestamp":1794832519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":27,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["20061"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20061-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No potential conflict of interest was reported by the authors.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This research was approved by the Ethics Committee of Peking University Third Hospital (approval number: IRB00006761-M2024200).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}